Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses

10 Feb 2025

Abstract excerpt

Respiratory viral infections present significant global health challenges, causing substantial morbidity and mortality, particularly among highly susceptible components of the population. The emergence of pandemics and epidemics, such as those caused by influenza viruses and coronaviruses, emphasizes the urgent need for effective antiviral therapeutics. In this review, we explore the potential of broad-spectrum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Respiratory viral infections research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40003946
DOI: 10.3390/ijms26041481

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA VirusesPMID 40003946Read ↗

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesSemantic proximity Read ↗

Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus InfectionsSemantic proximity Read ↗

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity Read ↗

Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsSemantic proximity Read ↗

Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2Semantic proximity Read ↗

Targeting viral genome synthesis as broad-spectrum approach against RNA virus infectionsSemantic proximity Read ↗

Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infectionSemantic proximity Read ↗

Antivirals and Biologics for Broader Coverage Against Human CoronavirusesSemantic proximity Read ↗

New treatments for influenzaSemantic proximity Read ↗

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesSemantic proximity Read ↗

Molecular pathology of emerging coronavirus infectionsSemantic proximity Read ↗

Receptors and host factors: key players in human metapneumovirus infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.